newsfilter
← Latest News
GlobeNewswire·

Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates

Avasopasem NDA granted FDA priority review for radiotherapy-induced severe oral mucositis (SOM); PDUFA target date of August 9, 2023 Company raised $30 million in gross proceeds from registered direct offering Company